Happify Health, a global leader in mental health technology, has signed an agreement with global biopharmaceutical compa...
Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA)...
The global epilepsy therapeutics market was valued at US$ 12.9 Bn in 2018 and is projected to expand at a compound annua...
3M Health Information Systems has introduced 3M™ M*Modal CDI Engage One™, a technology breakthrough resultin...
Process Systems Enterprise (PSE), the leading supplier of Advanced Process Modelling (APM) software and services, has an...
Sanofi and Abbott are partnering to integrate glucose sensing and insulin delivery technologies that would help to furth...
Medtronic plc and Novo Nordisk A/S have announced a collaboration that will develop solutions to integrate insulin ...
US based TAE Life Sciences, a company pioneering a new cancer treatment platform that addresses limitations in current c...
Strekin AG, a biopharmaceutical company focused on treatments for hearing loss, on 12 Sep 2019, announced that it has su...
Shimmer Research, a global leader in wearable technology for research applications, on 12 Sep 2019, announced the launch...
Certara®, the global model-informed drug development and decision support leader, on 12 Sep 2019, announced the laun...
More than two years after the infamous Wannacry ransomware crippled medical facilities and other organisations worldwide...
The Life Science division of Philip Morris International (PMI) has launched a computational challenge to identify and te...
GlaxoSmithKline has announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for use i...
GE Healthcare and Germfree are joining expertise to develop a fully integrated, expandable manufacturing solution for em...
Bristol-Myers Squibb Company has announced that its Board of Directors has elected three new independent Directors:...
The European Society of Cardiology (ESC) has published new clinical practice guidelines on the management of diabetes an...
New real world evidence (RWE) from the RELOADED and CALLIPER observational studies demonstrate rivaroxaban’s super...
